AGAP-2 antibody; Agap2 antibody; Agap2 ArfGAP with GTPase domain; ankyrin repeat and PH domain 2 antibody; AGAP2_HUMAN antibody; ANK repeat and PH domains 2 antibody; Arf GAP with GTP binding protein like antibody; Arf GAP with GTP-binding protein-like; ANK repeat and PH domains 2 antibody; Arf GAP with GTP-binding protein-like; ankyrin repeat and pleckstrin homology domains 2 antibody; Arf-GAP with GTPase; ANK repeat and PH domain-containing protein 2 antibody; ArfGAP with GTPase domain; ankyrin repeat and PH domain 2 antibody; Centaurin gamma 1 antibody; centaurin gamma1 antibody; Centaurin-gamma-1 antibody; Centg1 antibody; cnt g1 antibody; Cnt-g1 antibody; Cnt2 antibody; FLJ16430 antibody; GGAP2 antibody; GTP binding and GTPase activating protein 2 antibody; GTP-binding and GTPase activating protein 2 antibody; GTP-binding and GTPase-activating protein 2 antibody; KIAA0167 antibody; mKIAA0167 antibody; Nuclear GTPase PIKE antibody; Phosphatidylinositol 3-kinase enhancer antibody; Phosphoinositide 3 kinase enhancer antibody; PI3K ENHANCER antibody; PIKE antibody
Description:
The antibody against AGAP2 was raised in rabbit using the Human AGAP2 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC, IF.